A month into his new job as health and human services secretary, Robert F. Kennedy Jr. explained his view of America’s health ...

Donald Trump appeared to be catching up on some sleep as a key member of his administration launched a new health tracking ...

Apple, Google, and OpenAI join CMS in a major push to unify health records, boost AI tools, and improve patient access across ...

He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug ...

There are many signs that the Democratic and Republican Parties are in different places. Here’s one: The main Republican ...

President Donald Trump set a deadline of Sept. 19 for pharmaceutical companies to commit to complying with his demands of ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

Government programs may soon change how they approach a growing public health challenge that affects millions of Americans each year.

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

More than a dozen Democratic attorneys general announced a lawsuit challenging recent moves by President Trump’s ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...